Radiotherapy & Oncology
Volume 96, Issue 1 , Pages 13-18, July 2010

Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial

  • Abrahim Al-Mamgani

      Affiliations

    • Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands.
    • ,
  • Wilma D. Heemsbergen

      Affiliations

    • The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    • ,
  • Peter C. Levendag

      Affiliations

    • Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • ,
  • Joos V. Lebesque

      Affiliations

    • The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

Received 24 February 2009; received in revised form 19 February 2010; accepted 23 February 2010. published online 15 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0167-8140(10)00127-1

doi:10.1016/j.radonc.2010.02.022

Radiotherapy & Oncology
Volume 96, Issue 1 , Pages 13-18, July 2010

Article Tools

* Image Usage & Resolution